Arteris, Inc. (NASDAQ:AIP) Sees Significant Decline in Short Interest

Arteris, Inc. (NASDAQ:AIP) was the target of a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling 1,134,548 shares, a decrease of 14.8% from the January 15th total of 1,331,050 shares. Based on an average daily volume of 453,470 shares, the short-interest ratio is presently 2.5 days. Currently, 3.9% of the company’s shares are sold short. Currently, 3.9% of the company’s shares are sold short. Based on an average daily volume of 453,470 shares, the short-interest ratio is presently 2.5 days.

Key Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Q4 2025 results beat expectations: EPS of ($0.05) topped estimates and revenue of $20.14M beat consensus; management issued above‑consensus revenue guidance for Q1 and FY‑2026 — a clear fundamental positive supporting upside. Read More.
• Positive Sentiment: Commercial traction: Arteris reported its network‑on‑chip technology has shipped in over 4 billion devices, a credibility milestone that supports longer‑term revenue expansion in AI and edge markets. Read More.
• Positive Sentiment: Strategic moves: Management outlined a >$100M contract‑value target for 2026 and strengthened chip security capability via the Cycuity acquisition — both bolster the company’s addressable market and product offering. Read More.
• Positive Sentiment: Analyst/institutional support: Rosenblatt reaffirmed a Buy and $20 PT; several funds increased or initiated positions recently, which provides bench‑marked upside versus the current price.
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read‑throughs — these will be sources of further guidance detail and management color that could move shares. Read More.
• Neutral Sentiment: Short‑interest data in feeds is inconsistent (entries showing 0/NaN vs earlier reported short positions), so short‑squeeze risk is unclear until exchanges reconcile figures.
• Negative Sentiment: Large insider/major‑holder selling: CEO K. Charles Janac (and major holder Bayview Legacy, LLC) sold sizeable blocks in recent days (47,244 shares on Feb 9 plus additional sales), creating added supply and pressuring sentiment. Read More.
• Negative Sentiment: Mixed research view: some shops (Weiss) remain negative; consensus is a Hold with a $17.50 average target — divergent analyst views can increase short‑term volatility.

Arteris Stock Performance

Shares of NASDAQ AIP opened at $14.62 on Monday. Arteris has a 52-week low of $5.46 and a 52-week high of $19.85. The firm has a market capitalization of $664.77 million, a price-to-earnings ratio of -17.83 and a beta of 1.48. The stock has a 50 day moving average price of $16.23 and a 200 day moving average price of $13.31.

Arteris (NASDAQ:AIP) last released its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The firm had revenue of $20.14 million for the quarter, compared to analysts’ expectations of $18.55 million. Analysts forecast that Arteris will post -0.73 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on AIP. TD Cowen restated a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Jefferies Financial Group raised shares of Arteris to a “hold” rating in a research note on Tuesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Northland Securities set a $24.00 price target on Arteris in a report on Friday. Finally, Rosenblatt Securities reissued a “buy” rating and set a $20.00 price target on shares of Arteris in a research note on Friday. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $20.17.

Insider Buying and Selling at Arteris

In related news, major shareholder Bayview Legacy, Llc sold 2,756 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $15.03, for a total value of $41,422.68. Following the completion of the sale, the insider directly owned 9,349,071 shares in the company, valued at $140,516,537.13. This trade represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO K Charles Janac sold 2,756 shares of Arteris stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $15.03, for a total transaction of $41,422.68. Following the transaction, the chief executive officer directly owned 9,349,071 shares of the company’s stock, valued at $140,516,537.13. The trade was a 0.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 689,072 shares of company stock worth $11,525,611 over the last ninety days. Company insiders own 33.70% of the company’s stock.

Hedge Funds Weigh In On Arteris

Several institutional investors have recently bought and sold shares of AIP. Franklin Resources Inc. increased its holdings in shares of Arteris by 6.2% in the 4th quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock valued at $27,017,000 after acquiring an additional 101,646 shares during the period. Vanguard Group Inc. boosted its position in Arteris by 8.2% during the third quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company’s stock valued at $16,103,000 after purchasing an additional 120,947 shares in the last quarter. Westerly Capital Management LLC grew its stake in Arteris by 109.6% in the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after purchasing an additional 745,000 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Arteris by 144.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after purchasing an additional 598,840 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its holdings in shares of Arteris by 9.6% in the 2nd quarter. Acadian Asset Management LLC now owns 987,011 shares of the company’s stock valued at $9,403,000 after buying an additional 86,288 shares in the last quarter. 64.36% of the stock is owned by hedge funds and other institutional investors.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.